PDCD1 and neoplasm: Deleting PD-1 only in myeloid cells leads to metabolic reprogramming and the differentiation of myeloid-derived suppressor cells (MDSCs), resulting in increased effector memory T cells and decreased tumor growth despite preserved PD-1 expression in T cells in tumor-bearing mice [36].